An Open-Label, Multicenter, Randomized Phase Ib/II Study of Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
Titel:
An Open-Label, Multicenter, Randomized Phase Ib/II Study of Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
Auteur:
Waller, Cornelius F. Vynnychenko, Ihor Bondarenko, Igor Shparyk, Yaroslav Hodge, Jeffrey P. Freeman, Anne Huber, Brian Lieberman, Ronald Shelton, Mark J. Dave, Harish